Type 1 excludes
Type 2 excludes
Muscular dystrophies and myopathies (G71-G72)
Codes
Versions
2025
Code changed
Type 1 excludes
dermatopolymyositis (M33.-)myopathy in amyloidosis (E85.-)myopathy in polyarteritis nodosa (M30.0)myopathy in rheumatoid arthritis (M05.32)myopathy in scleroderma (M34.-)myopathy in Sjögren's syndrome (M35.03)myopathy in systemic lupus erythematosus (M32.-)
- dermatopolymyositis (M33.-)
- myopathy in amyloidosis (E85.-)
- myopathy in polyarteritis nodosa (M30.0)
- myopathy in rheumatoid arthritis (M05.32)
- myopathy in scleroderma (M34.-)
- myopathy in Sju00f6gren's syndrome (M35.03)
- myopathy in systemic lupus erythematosus (M32.-)
2024
No changes
2023
No changes
2022
Code changed
Type 1 excludes
dermatopolymyositis (M33.-)muscular dystrophies and myopathies (G71-G72)myopathy in amyloidosis (E85.-)myopathy in polyarteritis nodosa (M30.0)myopathy in rheumatoid arthritis (M05.32)myopathy in scleroderma (M34.-)myopathy in Sjögren's syndrome (M35.03)myopathy in systemic lupus erythematosus (M32.-)
- dermatopolymyositis (M33.-)
- myopathy in amyloidosis (E85.-)
- myopathy in polyarteritis nodosa (M30.0)
- myopathy in rheumatoid arthritis (M05.32)
- myopathy in scleroderma (M34.-)
- myopathy in Sjögren's syndrome (M35.03)
- myopathy in systemic lupus erythematosus (M32.-)
Type 2 excludes
- muscular dystrophies and myopathies (G71-G72)
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
No changes
2016
New code